C-33A人子宫颈癌细胞
文献支持

C-33A人子宫颈癌细胞

收藏
  • ¥1200
  • EK-Bioscience已认证
  • CB-Y1081
  • 2025年10月20日
    avatar
    品牌商
    11钻石会员
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    C-33A/C-33A细胞株/C-33A细胞系/C-33A人子宫颈癌细胞Cell line name C-33 A

    Synonyms C33A; C33a; C33-A; C-33-A; C-33A; C33

    Accession CVCL_1094

    Resource Identification Initiative To cite this cell line use: C-33 A (RRID:CVCL_1094)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: COSMIC cell lines project.

    Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).

    Population: Caucasian.

    Doubling time: 1.36 days (PubMed=29156801).

    Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).

    Omics: Deep exome analysis.

    Omics: Deep quantitative proteome analysis.

    Omics: DNA methylation analysis.

    Omics: Protein expression by reverse-phase protein arrays.

    Omics: Secretome proteome analysis by 2D-DE/MS.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.

    PubMed=6935474; DOI=10.1093/jnci/66.2.239

    Wright W.C., Daniels W.P., Fogh J.

    Distinction of seventy-one cultured human tumor cell lines by polymorphic enzyme analysis.

    J. Natl. Cancer Inst. 66:239-247(1981)

     

    PubMed=7459858

    Rousset M., Zweibaum A., Fogh J.

    Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins.

    Cancer Res. 41:1165-1170(1981)

     

    PubMed=2990217; PMCID=PMC1888002

    Yee C., Krishnan-Hewlett I., Baker C.C., Schlegel R., Howley P.M.

    Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

    Am. J. Pathol. 119:361-366(1985)

     

    PubMed=3518877; DOI=10.3109/07357908609038260

    Fogh J.

    Human tumor lines for cancer research.

    Cancer Invest. 4:157-184(1986)

     

    PubMed=1648218; DOI=10.1073/pnas.88.13.5523; PMCID=PMC51909

    Scheffner M., Munger K., Byrne J.C., Howley P.M.

    The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.

    Proc. Natl. Acad. Sci. U.S.A. 88:5523-5527(1991)

     

    PubMed=15531914; DOI=10.1038/sj.onc.1208235

    Baldus S.E., Schwarz E., Lohrey C., Zapatka M., Landsberg S., Hahn S.A., Schmidt D., Dienes H.-P., Schmiegel W.H., Schwarte-Waldhoff I.

    Smad4 deficiency in cervical carcinoma cells.

    Oncogene 24:810-819(2005)

     

    PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662

    Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.

    A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

    Cancer Res. 70:2158-2164(2010)

     

    PubMed=24134916; DOI=10.1186/1755-8166-6-44; PMCID=PMC3879223

    McCormack A., Fan J.-L., Duesberg M., Bloomfield M., Fiala C., Duesberg P.H.

    Individual karyotypes at the origins of cervical carcinomas.

    Mol. Cytogenet. 6:44.1-44.23(2013)

     

    PubMed=25485619; DOI=10.1038/nbt.3080

    Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S., Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.-M.

    A comprehensive transcriptional portrait of human cancer cell lines.

    Nat. Biotechnol. 33:306-312(2015)

     

    PubMed=25877200; DOI=10.1038/nature14397

    Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M., Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S., Neve R.M.

    A resource for cell line authentication, annotation and quality control.

    Nature 520:307-311(2015)

     

    PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878

    Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P., Loewer M., Sahin U., Castle J.C.

    TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

    Genome Med. 7:118.1-118.7(2015)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥780
    上海信裕生物科技有限公司
    2025年07月08日询价
    ¥780
    上海再康生物科技有限公司
    2025年11月21日询价
    询价
    上海雅吉生物科技有限公司
    2025年07月14日询价
    ¥1200
    上海晅科生物科技有限公司
    2025年07月12日询价
    询价
    上海晶风生物科技有限公司
    2025年05月31日询价
    文献支持
    C-33A人子宫颈癌细胞
    ¥1200